Skip to main content

Table 4 Logistic regression analysis of the correlation between SUA and MASLD based on stratified analysis according to BMI levels by gender

From: Gender difference in the association between serum uric acid and metabolic dysfunction-associated steatotic liver disease in patients with newly diagnosed type 2 diabetes

Males

 

Non-overweight/obesity

Overweight/obesity

 

OR

95% CI

P value

OR

95% CI

P value

 

Model 1

Model 1

SUA

1.012

1.007–1.018

 < 0.001*

1.017

1.012–1.022

 < 0.001*

 

Model 2

Model 2

SUA

1.011

1.004–1.016

0.002*

1.013

1.006–1.019

 < 0.001*

Females

 

Non-overweight/obesity

Overweight/obesity

 

OR

95% CI

P value

OR

95% CI

P value

 

Model 1

Model 1

SUA

1.011

1.005–1.016

 < 0.001*

0.998

0.994–1.002

0.248

 

Model 2

Model 2

SUA

1.009

1.002–1.016

0.015*

0.999

0.994–1.004

0.792

  1. Non-overweight/obesity group: BMI < 25 kg/m2, overweight/obesity group: BMI ≥ 25 kg/m2. Model 1: unadjusted analyses; Model 2: adjustment for BMI, age, SBP, DBP, ALT, AST, γ-GGT, FBG, TC, TG, LDL, HDL, SUN and Cr